Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

MD Medical opens a multidisciplinary hospital Michurinsky

11/13/23 MDMG

Board of Directors of NovaBev Group recommended that dividends be paid for 9 months 2023

11/13/23 BELU

RusAgro reported for 9 months of 2023

11/13/23 RAGR

Moscow Exchange's profit in Q3 increased by 64%

11/13/23 MOEX

Seligdar is going to sell 10% of Rusolovo shares

11/13/23 ROLO

Seligdar is going to sell 10% of Rusolovo shares

11/13/23 SELG

Segezha Group reported for 9 months of 2023 by IFRS

11/13/23 SGZH

Yuzhuralzoloto starts accepting applications for participation in the IPO

11/13/23 UGLD

Sollers localizes production of passive safety systems

11/13/23 SVAV

Slavneft-Megionneftegaz reported for 9 months of 2023 by RAS

11/13/23 MFGS